Target Name: OXT
NCBI ID: G5020
Review Report on OXT Target / Biomarker Content of Review Report on OXT Target / Biomarker
OXT
Other Name(s): MGC126890 | NEU1_HUMAN | Oxytocin, prepro- (neurophysin I) | Ocytocin | Oxytocin/neurophysin I prepropeptide | Pro-OXT | oxytocin, prepropeptide | OT | Pro-OT | Oxytocin-neurophysin 1 | Neurophysin I | OTTHUMP00000030079 | OXT-NP1_HUMAN | Neurophysin 1 | oxytocin, prepro- (neurophysin I) | OXT-NPI | neurophysin I | oxytocin-neurophysin I, preproprotein | Oxytocin | Oxytocin-neurophysin I | OT-NPI_HUMAN | MGC126892 | OT-NPI | oxytocin/neurophysin I prepropeptide

OXT: A Potent Antibiotic for Bacteria and Fungi

OXT (Oxytetracycline) is a tetracycline antibiotic that is commonly used to treat a range of bacterial and fungal infections. It works by interfering with the ability of the bacteria and fungi to produce a component of their cell walls, which is essential for their growth and survival. OXT has been shown to be effective in treating a wide range of bacterial and fungal infections, including urinary tract infections, acne, and foodborne infections.

One of the reasons OXT is so effective at treating bacterial and fungal infections is because it is able to enter the cells of these organisms and disrupt their ability to produce the cell wall component that is essential for their growth and survival. This interaction between OXT and the bacteria and fungi is highly specific, which means that it is able to effectively target and destroy the organisms that are causing the infection, while minimizing harm to healthy cells.

Another reason why OXT is an attractive drug target is that it is able to cross the blood-brain barrier, which is a barrier that separates the brain from the rest of the body. This allows OXT to be administered directly to the brain and can help to treat infections that are difficult to treat with other medications.

In addition to its effectiveness in treating bacterial and fungal infections, OXT has also been shown to have a number of potential potential applications as a drug target. For example, OXT has been shown to be able to interact with a variety of different signaling pathways in cells, which could lead to new insights into its potential mechanisms of action. Additionally, OXT has been shown to be able to alter the expression of genes in cells, which could be a useful tool for researchers to study the underlying biology of OXT and how it works.

Overall, OXT is a drug that has a lot of potential as a treatment for a wide range of bacterial and fungal infections. Its ability to enter cells and disrupt the ability of these organisms to produce cell wall components makes it an effective treatment for infections that are difficult to treat with other medications. Additionally, its ability to cross the blood-brain barrier and interact with a variety of different signaling pathways in cells makes it an attractive potential drug target for researchers to study the underlying biology of this compound.

Protein Name: Oxytocin/neurophysin I Prepropeptide

Functions: Neurophysin 1 specifically binds oxytocin

The "OXT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OXT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OXTR | Oxysterol-binding protein | Oxysterols receptor LXR | P2RX1 | P2RX2 | P2RX3 | P2RX4 | P2RX5 | P2RX5-TAX1BP3 | P2RX6 | P2RX6P | P2RX7 | P2RY1 | P2RY10 | P2RY10BP | P2RY11 | P2RY12 | P2RY13 | P2RY14 | P2RY2 | P2RY4 | P2RY6 | P2RY8 | P2X Receptor | P2Y purinoceptor | P3H1 | P3H2 | P3H3 | P3H4 | P3R3URF-PIK3R3 | P4HA1 | P4HA2 | P4HA3 | P4HB | P4HTM | PA28 Complex | PA28gamma Complex | PA2G4 | PA2G4P1 | PA2G4P4 | PAAF1 | PABIR1 | PABIR2 | PABIR3 | PABP-dependent poly(A) nuclease (PAN) complex | PABPC1 | PABPC1L | PABPC1L2A | PABPC1L2B | PABPC1P10 | PABPC1P2 | PABPC1P4 | PABPC1P7 | PABPC3 | PABPC4 | PABPC4-AS1 | PABPC4L | PABPC5 | PABPN1 | PABPN1L | PACC1 | PACERR | PACRG | PACRG-AS2 | PACRGL | PACS1 | PACS2 | PACSIN1 | PACSIN2 | PACSIN3 | PADI1 | PADI2 | PADI3 | PADI4 | PADI6 | PAEP | PAEPP1 | PAF1 | PAF1 complex | PAFAH1B1 | PAFAH1B2 | PAFAH1B2P2 | PAFAH1B3 | PAFAH2 | PAG1 | PAGE1 | PAGE2 | PAGE2B | PAGE3 | PAGE4 | PAGE5 | PAGR1 | PAH | PAICS | PAICSP4 | PAIP1 | PAIP1P1 | PAIP2 | PAIP2B | PAK1